Serum Gastric Level (Gastrin) at Dr. Essa Lab

Serum Gastric Level (Gastrin) at Dr. Essa Lab

The Serum Gastric Level (Gastrin) test is a highly specialized clinical laboratory investigation that measures the concentration of the hormone gastrin in the blood. Gastrin is a vital peptide hormone primarily synthesized, stored, and secreted by the endocrine G-cells located in the pyloric antrum of the stomach, the proximal duodenum, and the delta cells of the pancreas. This hormone plays a pivotal role in the human digestive system by stimulating the parietal cells of the stomach to secrete hydrochloric acid (HCl), which is essential for protein digestion and the destruction of ingested pathogens. Additionally, gastrin promotes gastric mucosal growth, enhances antral motility, and stimulates the release of histamine from enterochromaffin-like (ECL) cells, which further amplifies acid secretion.

Understanding the physiological feedback loop of gastrin is essential for appreciating the clinical value of this test. Under normal physiological conditions, the secretion of gastrin is regulated by a negative feedback mechanism. When food enters the stomach, the resulting distension, rise in pH, and presence of partially digested proteins stimulate G-cells to release gastrin into the bloodstream. As the gastrin stimulates parietal cells to produce hydrochloric acid, the gastric luminal pH drops. Once the pH falls below 2.0, a negative feedback loop is triggered, stimulating the release of somatostatin from D-cells, which subsequently inhibits further gastrin secretion. Disruption of this delicate feedback mechanism can lead to severe clinical disorders, making the Serum Gastric Level (Gastrin) test an invaluable diagnostic tool.

At Dr. Essa Lab, the premier diagnostic network in Karachi, Pakistan, the Serum Gastric Level (Gastrin) test is performed using advanced, fully automated chemiluminescent immunoassay (CLIA) technology. This state-of-the-art analytical platform ensures exceptional sensitivity, precision, and reproducibility, allowing for the detection of even minute variations in circulating gastrin levels. This test is of paramount clinical importance in evaluating patients presenting with chronic, severe, or atypical peptic ulcer disease, unexplained chronic diarrhea, or suspected neuroendocrine tumors. By providing accurate quantitative measurements of fasting serum gastrin, Dr. Essa Lab assists gastroenterologists, endocrinologists, and general physicians in establishing definitive diagnoses, monitoring therapeutic responses, and formulating targeted treatment strategies for complex gastrointestinal disorders.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the clinical accuracy and reliability of the Serum Gastric Level (Gastrin) test, strict adherence to patient preparation guidelines is mandatory. Because gastrin secretion is highly responsive to physiological stimuli, failure to prepare adequately can lead to false-positive or misleading results. Patients must follow these instructions carefully:

• Strict Fasting: The patient must undergo a strict fast of 12 hours prior to sample collection. Only plain water is permitted during this fasting period. Food intake, coffee, tea, and other beverages must be completely avoided, as they stimulate G-cells and cause a physiological rise in serum gastrin levels.
• Medication Discontinuation: Certain medications profoundly affect gastric acid secretion and, consequently, serum gastrin levels. Under the strict supervision and approval of the referring physician, patients may need to temporarily discontinue specific drugs:
  • Proton Pump Inhibitors (PPIs): Medications such as omeprazole, esomeprazole, lansoprazole, and pantoprazole must be discontinued for at least 10 to 14 days before the test. PPIs block gastric acid production, eliminating the negative feedback loop and causing a marked, reactive elevation in serum gastrin.
  • H2-Receptor Antagonists: Drugs like famotidine, ranitidine, and cimetidine should be discontinued for at least 48 hours prior to the test.
  • Antacids: Over-the-counter antacids should not be taken for at least 24 hours before sample collection.
• Avoid Alcohol and Nicotine: Patients must abstain from alcohol consumption and smoking for at least 24 hours before the test, as both substances can alter gastric mucosal function and hormone secretion.
• Stress Reduction: Physical and emotional stress can influence gastrointestinal hormone levels. Patients are advised to remain calm and rested before the blood draw.

During the Procedure

The Serum Gastric Level (Gastrin) test is a straightforward, minimally invasive blood test. When a patient visits one of the many state-of-the-art collection centers of Dr. Essa Lab in Karachi, they can expect a professional, hygienic, and streamlined experience:

• Patient Identification and Verification: The phlebotomist will verify the patient’s identity, confirm compliance with the 12-hour fasting requirement, and document any current medications, particularly acid-suppressing drugs.
• Venipuncture Site Selection: The patient will be seated comfortably. The phlebotomist will inspect the arm to locate a suitable vein, typically the median cubital vein in the antecubital fossa.
• Aseptic Preparation: The selected site is thoroughly cleansed with an antiseptic swab (70% isopropyl alcohol) and allowed to air dry to prevent hemolysis of the sample and ensure sterile conditions.
• Sample Collection: A sterile, single-use needle is inserted into the vein, and blood is drawn into a serum separator tube (SST) or a plain red-top tube. The tourniquet, if applied, is released promptly to prevent hemoconcentration.
• Post-Puncture Care: Once the required volume of blood is collected, the needle is gently withdrawn, and immediate pressure is applied to the site with a sterile cotton ball to prevent hematoma formation. A bandage is then applied.
• Immediate Sample Processing: Gastrin is a highly unstable peptide that is rapidly degraded by proteolytic enzymes present in serum at room temperature. To prevent pre-analytical errors, Dr. Essa Lab enforces strict sample handling protocols. The blood sample is allowed to clot, centrifuged promptly at a controlled temperature to separate the serum, and the serum is immediately frozen or kept on ice until analytical testing is performed.
• Safety and Comfort: The entire venipuncture process takes less than five minutes. Patients may feel a minor, brief prick as the needle enters the skin. The procedure is highly safe, with minimal risks restricted to localized bruising or mild soreness at the puncture site.

When is a Serum Gastric Level (Gastrin) Performed?

Suspected Zollinger-Ellison Syndrome (ZES)

Zollinger-Ellison Syndrome is a rare endocrine disorder characterized by the development of gastrin-secreting neuroendocrine tumors, known as gastrinomas. These tumors are most commonly located within the “gastrinoma triangle,” which is anatomically bounded by the porta hepatis, the duodenal sweep, and the pancreatic head. Gastrinomas secrete autonomous, unregulated, and massive quantities of gastrin, completely independent of physiological feedback mechanisms. This chronic hypergastrinemia drives the parietal cells into a state of hyperfunction and hyperplasia, resulting in extreme gastric acid hypersecretion. Clinicians request a Serum Gastric Level (Gastrin) test at Dr. Essa Lab when a patient presents with severe, recurrent, and atypical peptic ulcers that do not respond to standard medical therapies, or when ulcers are located in unusual anatomical sites such as the jejunum. Fasting gastrin levels exceeding 1,000 pg/mL in the presence of a gastric pH of less than 2.0 are highly diagnostic of ZES.

Chronic, Refractory Peptic Ulcer Disease

While the majority of peptic ulcers are caused by Helicobacter pylori infection or the chronic use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a subset of patients suffers from refractory peptic ulcer disease. These are ulcers that fail to heal despite compliance with standard therapeutic courses of proton pump inhibitors. In such challenging clinical scenarios, it is imperative to rule out underlying hypersecretory states. A Serum Gastric Level (Gastrin) test is performed to investigate whether the refractory nature of the ulcers is driven by pathological hypergastrinemia. Identifying the underlying hormonal imbalance allows gastroenterologists to transition from empirical acid suppression to targeted, disease-specific interventions, thereby preventing severe complications such as gastrointestinal hemorrhage, perforation, or stricture formation.

Evaluation of Pernicious Anemia and Achlorhydria

Pernicious anemia is an autoimmune condition characterized by the production of autoantibodies directed against gastric parietal cells and intrinsic factor. The progressive autoimmune destruction of parietal cells leads to severe mucosal atrophy of the gastric body and fundus, resulting in a profound loss of gastric acid production, a condition known as achlorhydria. Because gastric acid is the primary physiological inhibitor of gastrin secretion, its complete absence removes the negative feedback loop on antral G-cells. Consequently, the G-cells undergo compensatory hyperplasia and secrete massive amounts of gastrin into the circulation. Clinicians order the Serum Gastric Level (Gastrin) test to evaluate patients with macrocytic anemia, vitamin B12 deficiency, or suspected autoimmune gastritis. In these patients, extremely elevated serum gastrin levels, combined with a high gastric pH (greater than 5.0), confirm the diagnosis of achlorhydria associated with pernicious anemia, distinguishing it from gastrinoma.

Assessment of Gastric G-Cell Hyperplasia

Gastric G-cell hyperplasia is a pathological condition characterized by an abnormal increase in the number of gastrin-producing cells in the gastric antrum. This condition can be primary (idiopathic) or secondary to chronic acid suppression, gastric outlet obstruction, or a retained gastric antrum after surgical resection. Patients with G-cell hyperplasia present with clinical features that closely mimic Zollinger-Ellison Syndrome, including hypergastrinemia and gastric acid hypersecretion. The Serum Gastric Level (Gastrin) test, often performed in conjunction with a secretin stimulation test or a standardized meal stimulation test, is crucial for differentiating G-cell hyperplasia from a gastrinoma. In G-cell hyperplasia, serum gastrin levels rise significantly in response to a meal but do not show the paradoxical, extreme rise seen in gastrinomas following secretin administration, enabling precise clinical differentiation.

Monitoring Post-Surgical Gastrinoma Resection

For patients diagnosed with localized gastrinomas, surgical resection represents the primary curative treatment modality. Following surgical intervention, long-term monitoring is essential to assess the completeness of the resection and to detect early tumor recurrence or metastatic disease. The Serum Gastric Level (Gastrin) test is utilized as a highly sensitive biochemical marker during post-operative follow-up. A rapid return of fasting serum gastrin levels to the normal reference range indicates successful and complete tumor clearance. Conversely, persistently elevated gastrin levels in the immediate post-operative period suggest residual tumor tissue, while a subsequent rise in gastrin levels after a period of normalcy indicates tumor recurrence or metastasis, typically to the liver or regional lymph nodes, prompting immediate localization via advanced imaging.

What Does a Serum Gastric Level (Gastrin) Detect?

The Serum Gastric Level (Gastrin) test is a powerful diagnostic tool capable of detecting and differentiating a wide spectrum of physiological, pharmacological, and pathological conditions. By measuring the precise concentration of circulating gastrin, this test assists in the detection and evaluation of:

• Zollinger-Ellison Syndrome (ZES): Characterized by autonomous, massive gastrin secretion from neuroendocrine tumors.
• Duodenal Gastrinomas: Small, often multiple tumors located in the submucosa of the duodenum.
• Pancreatic Gastrinomas: Neuroendocrine tumors located within the pancreatic parenchyma, often larger and more prone to metastasis.
• Multiple Endocrine Neoplasia Type 1 (MEN1): An autosomal dominant genetic disorder where gastrinomas are associated with parathyroid and pituitary tumors.
• Autoimmune Chronic Atrophic Gastritis (Type A): Autoimmune destruction of the gastric corpus, leading to loss of parietal cells.
• Pernicious Anemia: Severe vitamin B12 deficiency resulting from autoimmune-mediated loss of intrinsic factor and gastric acid.
• Achlorhydria: The complete absence of hydrochloric acid in gastric secretions, leading to compensatory hypergastrinemia.
• Hypochlorhydria: Subnormal levels of gastric acid production, causing mild to moderate elevations in serum gastrin.
• Antral G-Cell Hyperplasia (Primary): An idiopathic proliferation of G-cells leading to autonomous hypersecretion of gastrin.
• Secondary G-Cell Hyperplasia: Proliferation of G-cells driven by chronic gastric hypoacidity or mechanical distension.
• Drug-Induced Hypergastrinemia (PPI Therapy): Reactive elevation of gastrin due to long-term use of proton pump inhibitors.
• Drug-Induced Hypergastrinemia (H2-Blocker Therapy): Elevation of gastrin secondary to acid suppression by histamine H2-receptor antagonists.
• Helicobacter pylori Infection: Chronic infection of the gastric mucosa, which can cause localized inflammation, impair somatostatin release, and lead to mild hypergastrinemia.
• Chronic Kidney Disease (CKD): Renal insufficiency leads to reduced clearance and excretion of circulating gastrin, resulting in elevated serum levels.
• Gastric Outlet Obstruction: Mechanical obstruction of the pylorus causing chronic antral distension, which mechanically stimulates G-cells to release gastrin.
• Retained Gastric Antrum Syndrome: A post-surgical complication where a remnant of the antrum is inadvertently left in contact with the alkaline duodenal secretions after a Billroth II reconstruction, causing continuous gastrin release.
• Short Bowel Syndrome: Hypergastrinemia occurring after massive small bowel resection due to the loss of inhibitory hormones normally secreted by the distal gut.
• Vagotomy State: Surgical cutting of the vagus nerve, which reduces acid secretion and leads to a compensatory rise in gastrin.
• Gastric Carcinoma: Certain types of gastric adenocarcinomas associated with long-standing chronic atrophic gastritis and hypergastrinemia.
• Gastric Neuroendocrine Tumors (Type I NETs): Benign carcinoid tumors arising from ECL cells due to chronic trophic stimulation by high gastrin levels in autoimmune gastritis.
• Physiological Postprandial State: Temporary, normal elevation of gastrin following food ingestion (detected if fasting guidelines are not followed).
• Normal Gastric Physiology: Confirms normal hormonal regulation and rules out primary gastrin-secreting tumors or severe acid-suppressive states.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab, established in 1987 by the renowned Prof. Dr. M. Essa Abdullah, is widely recognized across Karachi and Pakistan for its commitment to diagnostic accuracy, clinical excellence, and rapid service delivery. Understanding that timely diagnostic results are critical for anxiety relief and prompt clinical decision-making, Dr. Essa Lab has optimized its pre-analytical, analytical, and post-analytical workflows.

The Serum Gastric Level (Gastrin) test is processed using advanced, fully automated immunoassay analyzers under the strict supervision of qualified clinical biochemists and consultant pathologists. The typical turnaround time (TAT) for this specialized test is 24 to 48 hours from the time of sample collection. Once the analysis is complete and the results are verified through rigorous internal quality control protocols, reports are immediately uploaded to the secure digital database.

Patients and referring physicians can access reports conveniently through multiple channels:

• Online Web Portal: Reports can be viewed, downloaded, and printed directly from the official Dr. Essa Lab website by entering the unique patient ID and password provided on the receipt.
• WhatsApp Delivery: For enhanced convenience, patients can opt to receive their verified PDF reports directly on their registered mobile numbers via WhatsApp.
• Mobile Application: The Dr. Essa Lab mobile app provides a user-friendly interface to track test status, view historical reports, and manage health records.
• Physical Collection: Patients can also collect high-quality, printed physical reports from any of the numerous Dr. Essa Lab collection centers located strategically across Karachi.

Serum Gastric Level (Gastrin) Findings Overview

The interpretation of serum gastrin levels must always be performed in conjunction with the measurement of gastric pH, as the clinical significance of hypergastrinemia differs fundamentally depending on whether the stomach is highly acidic or achlorhydric. The following table provides a comprehensive clinical overview of potential findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Fasting Serum Gastrin Level	Typically < 100 pg/mL (may vary slightly by assay)	Elevated (> 100 pg/mL to > 1,000 pg/mL) indicating hypergastrinemia.
Gastric pH Correlation	pH < 3.0 (normal acidic environment)	pH < 2.0 with high gastrin (suggests Gastrinoma/ZES); pH > 5.0 with high gastrin (suggests Pernicious Anemia/Atrophic Gastritis).
Secretin Stimulation Test	No significant rise or a decrease in serum gastrin	Paradoxical, dramatic rise in gastrin (> 200 pg/mL above baseline) confirming Gastrinoma.
Renal Function (eGFR)	Normal renal clearance of gastrin peptides	Elevated serum gastrin due to impaired renal clearance in chronic kidney disease.
Parietal Cell Antibodies	Negative (no autoimmune destruction)	Positive, indicating autoimmune chronic atrophic gastritis and pernicious anemia.
Helicobacter pylori Status	Negative	Positive, associated with mild to moderate reactive hypergastrinemia.
Acid-Suppressive Therapy	No active medication use	Markedly elevated gastrin levels secondary to active PPI or H2-blocker therapy.
Post-Surgical Baseline	Undetectable or low normal gastrin levels	Persistently elevated or rising gastrin levels indicating incomplete resection or recurrence.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Serum Gastric Level (Gastrin)?

• Decades of Diagnostic Excellence: Established in 1987 by Prof. Dr. M. Essa Abdullah, Dr. Essa Lab is one of Pakistan’s most trusted diagnostic networks.
• ISO Certified Quality Standards: Operating under strict international quality management systems, ensuring highly reliable and accurate test results.
• Advanced Immunoassay Technology: Utilizing state-of-the-art, fully automated chemiluminescent immunoassay (CLIA) platforms for precise hormone quantification.
• Expert Pathologist Supervision: All specialized endocrine and biochemical assays are supervised and verified by highly qualified consultant pathologists.
• Convenient Home Sample Collection: Offering professional home health services across Karachi, allowing patients to have their blood drawn in the comfort of their homes.
• Rapid Turnaround Time: Efficient laboratory workflows ensure that specialized gastrin reports are available within 24 to 48 hours.
• Seamless Digital Access: Easy report retrieval via the official website portal, dedicated mobile app, and direct WhatsApp delivery.
• Extensive Network: Over dozens of convenient collection centers across Karachi and Sindh, making high-quality diagnostics accessible to all.